|
CQDM
|
Nous accélérons la découverte du médicament !
CQDM is a pharma-based consortium active in biopharmaceutical research whose mission is to fund the development of innovative tools and technologies to accelerate drug discovery. Unique in the world, CQDM’s business model is based on a collaborative approach where all stakeholders share the costs of biopharmaceutical research and benefit from its results. CQDM also provides a common meeting ground where academia, governments, biotechs and the pharmaceutical industry converge to address numerous complex medical challenges. CQDM receives financial support from Merck, Pfizer Inc., AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Eli Lilly Canada, Janssen, Novartis Pharma Canada, Sanofi Canada, as well as from Quebec’s Ministry of Economy, Science and Innovation (MESI) and from the Government of Canada under the Business-Led Networks of Centres of Excellence Program (BL-NCE). For more information: www.cqdm.org.
|
|
|
Hang in there, our digital helpers are on the case! Your curiosity is contagious! Our AI butterflies are fluttering around, creating something special just for you! Our digital team is like a family of penguins, working together to bring you the coolest response! Your message has set our digital fireflies aglow. They're illuminating the path to your perfect response! We're like a digital bakery, and your response is in the oven, getting ready to be served piping hot!
Follow this employer
Apply
Favorite
Share
Apply
Applied
Applied
Favorite
Share
